Despite its high prevalence worldwide, alcoholic liver disease (ALD) has attracted little attention in the past two decades. Abstinence has been the most effective therapy, but targeted therapies are required for severe forms. Novel potential therapeutic targets have been identified, but their pathogenetic roles remain unknown. This Review summarizes the epidemiology, risk factors and current knowledge of ALD, including discussion of new therapeutic targets.